Advances in the regulatory mechanisms of mTOR in necroptosis
mTOR regulates necroptosis via various mechanisms. mTOR inhibits autophagy, which suppresses necroptosis by disturbing the interaction between RIPK1 and RIPK3. Autophagy specifically recognizes and degrades ubiquitinated RIPK3 and negatively affects necroptosis. Furthermore, damaged mitochondria are the primary source of ROS, which can activate RIPK1 directly and promote the interaction between RIPK1 and RIPK3, facilitating the assembly of necrosomes. Mitophagy restrains ROS production by eliminating injured mitochondria. Furthermore, RIPK1 can be activated by mTOR directly through phosphorylation. mTOR can elevate the level of TNRα mRNA and promote the autocrine effect of TNFα by activating the JNK pathway, both of which can boost necroptosis. Tipping the balance of the redox reaction is another approach for mTOR to regulate necroptosis. p62 assists with the release and stabilization of Nrf2 by counteracting Keap1, and the released Nrf2 translocates to the nucleus and governs the expression of genes associated with antioxidant defense to antagonize necroptosis. mTOR displays bidirectional effects on this process. On the one hand, mTOR inhibits p62 to promote necroptosis, thereby suppressing the antioxidant reaction. In contrast, mTOR promotes nuclear translocation to inhibit necroptosis. TNF-α, tumor necrosis factor-α; TNFR1, tumor necrosis factor receptor; TRADD, TNF receptor type 1 associated death domain; TRAF2, TNF receptor associated factor 2; RIPK, receptor-interacting serine-threonine kinase; LUBAC, linear ubiquitin chain assembly complex; cIAP1/2, cellular inhibitors of apoptosis 1/2; TAK1, transforming growth factor-β-activated kinase1; TAB2, TAK1-binding protein2; IKKα/β, IKK complex constituted of IκB kinase α/β; NEMO, NF-κB essential modulator; MAPK, mitogen-activated protein kinase; CYLD, Cylindromatosis; OTULIN, OTU deubiquitinase with linear linkage specificity; cFLIP, cellular FLICE-like inhibitory protein; CASP, caspase; FADD, Fas associated death domain; DISC, death-inducing signaling complex; MLKL, mixed lineage kinase domain-like protein; TLR, toll-like receptor; TRIF, Toll/IL-1 receptor domain-containing adaptor protein inducing interferon-β; dsRNA, double-stranded RNA; LPS, lipopolysaccharide; ROS, reactive oxygen species; Nrf2, nuclear factor-erythroid 2-related factor 2; Keap1, Kelch-like ECH-associated protein 1.